H. Durox
Impact in
- Biotechnology top 2%
- Listeria monocytogenes in Food Safety
- Epidemiology top 5%
- Infective Endocarditis Diagnosis and Management
Papers in
- Epidemiology 17
- Infective Endocarditis Diagnosis and Management 9
- Nonmelanoma Skin Cancer Studies 4
-
- HIV/AIDS Research and Interventions 3
- Antifungal resistance and susceptibility 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- É. Denes (8 shared papers)A. Sparsa (11 shared papers)C. Bédane (9 shared papers)V. Doffoël-Hantz (7 shared papers)P. Weinbreck (5 shared papers)Serge Boulinguez (2 shared papers)Jean‐Michel Gaulier (1 shared paper)Franck [email protected] (1 shared paper)
In The Last Decade
H. Durox
34 papers receiving 1.5k citations
H. Durox's Hit Papers
Peers
Comparison fields: 5 of 77
- Biotechnology 244
- Epidemiology 743
- Microbiology 89
- Infectious Diseases 155
- Virology 31
Countries citing papers authored by H. Durox
This map shows the geographic impact of H. Durox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Durox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Durox more than expected).
Fields of papers citing papers by H. Durox
This network shows the impact of papers produced by H. Durox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Durox. The network helps show where H. Durox may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Durox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study Hit paper breakdown → | 2019 | 585 |
| 2 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 397 |
| 3 | 2019 | 56 | |
| 4 | 2022 | 53 | |
| 5 | 2022 | 48 | |
| 6 | 2007 | 39 | |
| 7 | Blue light is phototoxic for B16F10 murine melanoma and bovine endothelial cell lines by direct cytocidal effect. | 2010 | 39 |
| 8 | 2021 | 33 | |
| 9 | 2010 | 30 | |
| 10 | 2023 | 29 | |
| 11 | 2010 | 26 | |
| 12 | 2022 | 25 | |
| 13 | 2022 | 23 | |
| 14 | 2019 | 17 | |
| 15 | 2011 | 16 | |
| 16 | 2014 | 16 | |
| 17 | 2008 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2008 | 8 | |
| 20 | 2023 | 8 |
About H. Durox
H. Durox is a scholar working on Epidemiology, Infectious Diseases, Surgery, Dermatology and Pathology and Forensic Medicine, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (9 papers), Orthopedic Infections and Treatments (5 papers), Nonmelanoma Skin Cancer Studies (4 papers), HIV/AIDS Research and Interventions (3 papers), Infectious Diseases and Tuberculosis (3 papers), Antifungal resistance and susceptibility (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Biotechnology (244 citations), Epidemiology (743 citations), Microbiology (89 citations), Infectious Diseases (155 citations) and Virology (31 citations). H. Durox has collaborated with scholars based in France, Italy and Belgium. Frequent co-authors include É. Denes, A. Sparsa, C. Bédane, V. Doffoël-Hantz, P. Weinbreck, Serge Boulinguez, Jean‐Michel Gaulier, Franck [email protected], Marie‐Laure Dardé and A. Boumédiène. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, European Heart Journal, European Heart Journal - Quality of Care and Clinical Outcomes, Open Forum Infectious Diseases and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.